These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 6203761)
1. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761 [TBL] [Abstract][Full Text] [Related]
2. Irreversible blockade of central 5-HT binding sites by 8-methoxy-2'-chloro-PAT. Emerit MB; Gozlan H; Hall MD; Hamon M; Marquet A Biochem Pharmacol; 1985 Mar; 34(6):883-92. PubMed ID: 3156602 [TBL] [Abstract][Full Text] [Related]
3. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Gozlan H; El Mestikawy S; Pichat L; Glowinski J; Hamon M Nature; 1983 Sep 8-14; 305(5930):140-2. PubMed ID: 6225026 [TBL] [Abstract][Full Text] [Related]
4. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site. Middlemiss DN Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235 [TBL] [Abstract][Full Text] [Related]
5. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780 [TBL] [Abstract][Full Text] [Related]
6. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain. Ransom RW; Asarch KB; Shih JC J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490 [TBL] [Abstract][Full Text] [Related]
7. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT. Emerit MB; Gozlan H; Marquet A; Hamon M Eur J Pharmacol; 1986 Aug; 127(1-2):67-81. PubMed ID: 2944752 [TBL] [Abstract][Full Text] [Related]
8. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Hoyer D; Engel G; Kalkman HO Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents. Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581 [TBL] [Abstract][Full Text] [Related]
10. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice. Green AR; DeSouza RJ; Davies EM; Cross AJ Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944 [TBL] [Abstract][Full Text] [Related]
11. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat. Burnet PW; Mefford IN; Smith CC; Gold PW; Sternberg EM J Neurochem; 1992 Sep; 59(3):1062-70. PubMed ID: 1379629 [TBL] [Abstract][Full Text] [Related]
12. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum. Alexander BS; Wood MD J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists. Devivo M; Maayani S Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612 [TBL] [Abstract][Full Text] [Related]
14. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat. Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543 [TBL] [Abstract][Full Text] [Related]
15. Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site. Gozlan H; Emerit MB; el Mestikawy S; Cossery JM; Marquet A; Besselievre R; Hamon M J Recept Res; 1987; 7(1-4):195-221. PubMed ID: 2957498 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum. Bonanno G; Maura G; Raiteri M Eur J Pharmacol; 1986 Jul; 126(3):317-21. PubMed ID: 2944750 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Dumuis A; Sebben M; Bockaert J Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913 [TBL] [Abstract][Full Text] [Related]
18. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. Raiteri M; Maura G; Bonanno G; Pittaluga A J Pharmacol Exp Ther; 1986 May; 237(2):644-8. PubMed ID: 2871177 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. De Vivo M; Maayani S J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565 [TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat. Mørk A; Geisler A Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]